Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online October 19, 2006
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2006-0420v1
25/2/425    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lian, Q.
Right arrow Articles by Lim, S.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lian, Q.
Right arrow Articles by Lim, S.-K.
Submitted on July 12, 2006
Accepted on October 11, 2006

Embryonic Stem Cells

Derivation of Clinically Compliant MSCs from CD105+, CD24- Differentiated Human ESCs

Qizhou Lian 1, Elias Lye 1, Keng Suan Yeo 2, Eileen Khia Way Tan 2, Manuel Salto-Tellez 3, Tong Ming Liu 4, Nallasivam Palanisamy 2, Reida Menshawe El Oakley 5, Eng Hin Lee 6, Bing Lim 7, Sai-Kiang Lim 8*

1 Department of Surgery, National University of Singapore, Singapore, Singapore; Genome Institute of Singapore, Singapore, Singapore
2 Genome Institute of Singapore, Singapore, Singapore
3 Department of Pathology, National University of Singapore, Singapore, Singapore
4 Genome Institute of Singapore, Singapore, Singapore; Department of Orthopaedic Surgery, National University of Singapore, Singapore, Singapore
5 Department of Surgery, National University of Singapore, Singapore, Singapore
6 Department of Orthopaedic Surgery, National University of Singapore, Singapore, Singapore
7 Genome Institute of Singapore, Singapore, Singapore; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
8 Genome Institute of Singapore, Singapore, Singapore; Department of Biochemistry, National University of Singapore, Singapore, Singapore

* To whom correspondence should be addressed. E-mail: limsk{at}gis.a-star.edu.sg.


   Abstract

Adult tissue-derived mesenchymal stem cells (MSCs) have demonstrated therapeutic efficacy in treating diseases or repairing damaged tissues through mechanisms thought to be mediated by either cell replacement or secretion of paracrine factors. Characterized, self-renewing human ESCs could potentially be an invariable source of consistently uniform MSCs for therapeutic applications. Here we describe a clinically relevant and reproducible manner of generating identical batches of hESC-derived MSC (hESC-MSC) cultures that circumvents exposure to virus, mouse cells or serum. Trypsinization and propagation of HuES9 or H1 hESCs in feeder- and serum-free selection media generated three polyclonal, karyotypically stable and phenotypically MSC-like cultures that do not express pluripotency-associated markers but displayed MSC-like surface antigens and gene expression profile. They differentiate into adipocytes, osteocytes and chondrocytes in vitro. Gene expression and FACS analysis identified CD105 and CD24 as highly expressed antigens on hESC-MSCs and hESCs respectively. CD105+, CD24- monoclonal isolates have a typical MSC gene expression profiles and were identical to each other with a highly correlated gene expression profile (r2>0.90). We have developed a protocol to reproducibly generate clinically compliant and identical hESC-MSC cultures.

Key Words. Human embryonic stem cells, mesenchymal stem cells, cell surface markers, adipogenesis, Chondrogenesis, Osteoprogenitor, Selectable marker, Somatic stem cells




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
H. Tapp, E. N. Hanley Jr., J. C. Patt, and H. E. Gruber
Adipose-Derived Stem Cells: Characterization and Current Application in Orthopaedic Tissue Repair
Experimental Biology and Medicine, January 1, 2009; 234(1): 1 - 9.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. S. Hwang, S. Varghese, H. J. Lee, Z. Zhang, Z. Ye, J. Bae, L. Cheng, and J. Elisseeff
In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells
PNAS, December 30, 2008; 105(52): 20641 - 20646.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
S. K. Sze, D. P. V. de Kleijn, R. C. Lai, E. Khia Way Tan, H. Zhao, K. S. Yeo, T. Y. Low, Q. Lian, C. N. Lee, W. Mitchell, et al.
Elucidating the Secretion Proteome of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells
Mol. Cell. Proteomics, October 1, 2007; 6(10): 1680 - 1689.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
W. S. Toh, Z. Yang, H. Liu, B. C. Heng, E. H. Lee, and T. Cao
Effects of Culture Conditions and Bone Morphogenetic Protein 2 on Extent of Chondrogenesis from Human Embryonic Stem Cells
Stem Cells, April 1, 2007; 25(4): 950 - 960.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2006 by AlphaMed Press.